# Efficiency and Safety a Fixed Combination of Orphenadrine and Diclofenac for Postoperative Analgesia

> **NCT05322603** · NA · COMPLETED · sponsor: **Petrovsky National Research Centre of Surgery** · enrollment: 60 (actual)

## Conditions studied

- Analgesia

## Interventions

- **DRUG:** Analgesics Non Opioid (Neodolpasse manufactured by Fresenius Kabi)
- **DRUG:** Analgesics

## Key facts

- **NCT ID:** NCT05322603
- **Lead sponsor:** Petrovsky National Research Centre of Surgery
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-18
- **Primary completion:** 2022-08-20
- **Final completion:** 2022-08-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05322603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05322603, "Efficiency and Safety a Fixed Combination of Orphenadrine and Diclofenac for Postoperative Analgesia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05322603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*